Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,607,937
-$2,121,941 QoQ
Shares Held
22,376
-29.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#534
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,280,484 | $77,262,797 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
72,306 | $39,177,559 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,129,781 | $39,169,506 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
1,618,404 | $23,450,672 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
368,017 | $17,116,470 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,477,494 | $15,897,835 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
333,656 | $8,211,273 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
16,253 | $2,739,280 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,607,937 | 22,376 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,729,878 | 31,553 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,213,853 | 41,439 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $23,704,131 | 162,002 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $22,282,914 | 142,885 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $28,937,236 | 175,750 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $40,036,136 | 245,726 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $46,804,645 | 239,557 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $49,497,919 | 285,521 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $100,390,427 | 593,289 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $129,848,732 | 657,895 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $121,465,700 | 698,159 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $105,555,428 | 612,946 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $98,080,592 | 589,285 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $55,221,502 | 376,810 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $82,495,651 | 556,313 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $101,134,573 | 588,368 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $90,076,239 | 477,630 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $109,193,418 | 447,459 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $76,691,122 | 395,030 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $89,458,387 | 480,030 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $73,192,765 | 464,775 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $70,111,260 | 423,633 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $63,993,889 | 386,974 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $18,750,086 | 136,822 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $15,704,199 | 133,437 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||